Dr. Naji Tawfik, MD – Evansville, IN
Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis
Alan Menter, et al, for the Efalizumab Study Group (Tawfik, N.), Archives of Dermatology, 1/1/2005Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies
Geisse, J., et al (Tawfik, N.), J Am Acad Dermatology, 1/1/2004Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials
Lebwohl, M., Tawfik N.H., et al, J Am Acad Dermatology, 1/1/2004
